Pfizer Global Medical Grants (GMG) – Now LIVE!

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

 I would like to share a new RFP that may be of interest to you. This RFP is focused on supporting independent research initiatives.

 If you have any questions about this RFP or the grant application process, please contact my colleague, Jessica Romano, at [email protected].


 

Grant 1: 2022/2023 Global Cachexia ASPIRE

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research program. An ISR grant request cannot be submitted for a study that has already commenced and was not originally supported by Pfizer.

 

Date RFP Issued: September 20, 2022

Geographic Scope: Global

Clinical Area: Cachexia

Link to full RFP: 2022/2023 Global Cachexia ASPIRE

Application Due Date: January 5, 2023

Specific Area of Interest: The intent of this RFP is to support research projects in the following categories:

Evidence generation in Understanding Cachexia/Unintentional Weight Loss in Cancer or Heart Failure
Role of GDF-15/GFRAL Pathway in Disease
GDF-15/GFRAL Biology
Natural History (longitudinal) studies specifically related to cachexia/weight loss and/or heart failure


 

Grant 2: Engaging the Patient Community in Research and Publications

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to help improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s areas of interest. Consistent with Pfizer’s commitment to putting patients first, we are proud to collaborate with the Stanford Medicine AIM lab to release this RFP to support patient-powered research.

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

 

Date RFP Issued: October 20, 2022

Geographic Scope: United States, Canada and Europe

Clinical Area: Infectious disease, drug resistant infections, Oncology and Internal Medicine

Link to full RFP: Engaging the Patient Community in Research and Publications

Application Due Date: December 8, 2022

Specific Area of Interest: Through this RFP, we intend to provide grants to strengthen the capabilities of the patient community by providing mentorship and training on how to conduct patient-partnered research with the goal to facilitate increased opportunities for collaboration between patients and academic-research communities.

Latest News

By UK SACT Board Representatives - Joseph Williams and Netty Cracknell on 16th September 2025

Proposals for the reshaping of cancer services in England: funding for innovative cancer treatments

The Royal College of Radiologists (RCR) and the Society of Radiographers (SoR) have published a short document that expands on previous proposals for improving funding arrangements to enable equitable access…

Read article
By BOPA Exec Committee on 15th September 2025

Invitation to visit the BOPA stand at the BOPA Conference in Belfast

Hello All As an Executive Committee we are looking forward to meeting those of you who are signed up to come to the conference in Belfast next month. The BOPA…

Read article
By BOPA Research subcommittee on 14th September 2025

Survey: Fertility and the use of Immune Checkpoint Inhibitor Therapy (Survey from Royal Marsden Hospital)

Immune checkpoint inhibitors, such as atezolizumab, nivolumab and pembrolizumab have transformed the treatment landscape for many cancers. Cancers such as melanoma and Lynch-syndrome related tumours necessitating immune checkpoint inhibitors are…

Read article
By Clayton Wong on 8th September 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 21-22 November 2025 | Manchester Central Confirm your free delegate place *free places are only available for registered healthcare…

Read article